相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancer
Xiao-hong Mao et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
Immune Infiltrates in Breast Cancer: Recent Updates and Clinical Implications
Maria Vittoria Dieci et al.
CELLS (2021)
Overexpression of CCNE1 confers a poorer prognosis in triple-negative breast cancer identified by bioinformatic analysis
Qianqian Yuan et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
A first report of a rare TP53 variant associated with Li-Fraumeni syndrome manifesting as invasive breast cancer and malignant solitary fibrous tumor
Juraj Prejac et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
miR-381-3p suppresses breast cancer progression by inhibition of epithelial-mesenchymal transition
Yong-Zheng Yu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
In silico analysis of differentially expressed genesets in metastatic breast cancer identifies potential prognostic biomarkers
Jongchan Kim
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
Large-Scale Transcriptome Analysis Identified a Novel Cancer Driver Genes Signature for Predicting the Prognostic of Patients With Hepatocellular Carcinoma
Gao Li et al.
FRONTIERS IN PHARMACOLOGY (2021)
Driver Gene Mutations and Epigenetics in Colorectal Cancer
Hans Raskov et al.
ANNALS OF SURGERY (2020)
Network control principles for identifying personalized driver genes in cancer
Wei-Feng Guo et al.
BRIEFINGS IN BIOINFORMATICS (2020)
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
Peter Schmid et al.
LANCET ONCOLOGY (2020)
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
Wen-juan Liu et al.
PHARMACOLOGY & THERAPEUTICS (2020)
BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition
Weihong Niu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Pembrolizumab for Early Triple-Negative Breast Cancer
Peter Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
CD8-positive memory T cells in tumor-draining lymph nodes of patients with breast cancer
Yasmin Vahidi et al.
BMC CANCER (2020)
Not all cancers are created equal: Tissue specificity in cancer genes and pathways
Joy J. Bianchi et al.
CURRENT OPINION IN CELL BIOLOGY (2020)
Identification of key differentially expressed genes and gene mutations in breast ductal carcinoma in situ using RNA-seq analysis
Congyuan Zhu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
Oncogenic driver genes and tumor microenvironment determine the type of liver cancer
Gang Wang et al.
CELL DEATH & DISEASE (2020)
The Role of CCL21/CCR7 Chemokine Axis in Breast Cancer Progression
Balsam Rizeq et al.
CANCERS (2020)
Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis
Rong Jia et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
Investigation of the SPAG5 gene expression and amplification related to the NuMA mRNA levels in breast ductal carcinoma
Zeinab Mohamadalizadeh-Hanjani et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
Prognostic biomarkers related to breast cancer recurrence identified based on Logit model analysis
Xiaoying Zhou et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
A Novel Promoter CpG-Based Signature for Long-Term Survival Prediction of Breast Cancer Patients
Yang Guo et al.
FRONTIERS IN ONCOLOGY (2020)
A compendium of mutational cancer driver genes
Francisco Martinez-Jimenez et al.
NATURE REVIEWS CANCER (2020)
Identification of a novel glycolysis-related gene signature that can predict the survival of patients with lung adenocarcinoma
Chang Liu et al.
CELL CYCLE (2019)
Detailed modeling of positive selection improves detection of cancer driver genes
Siming Zhao et al.
NATURE COMMUNICATIONS (2019)
Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts
Guochun Zhang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
A novel network control model for identifying personalized driver genes in cancer
WeiFeng Guo et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study
S. Adams et al.
ANNALS OF ONCOLOGY (2019)
Prognostic Role of KRAS mRNA Expression in Breast Cancer
Ki-Tae Hwang et al.
JOURNAL OF BREAST CANCER (2019)
Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC
Xue Li et al.
CANCER LETTERS (2018)
Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression
Anne Bruun Kroigard et al.
PLOS ONE (2018)
Digital gene expression profiling analysis and its application in the identification of genes associated with improved response to neoadjuvant chemotherapy in breast cancer
Xiaozhen Liu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
Assessment of expression of interferon γ (IFN-G) gene and its antisense (IFNG-AS1) in breast cancer
Hajar Yaghoobi et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
Suppressor of cytokine signaling (SOCS) genes are downregulated in breast cancer
Soudeh Ghafouri-Fard et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
Prognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancer
Carmen Criscitiello et al.
EUROPEAN JOURNAL OF CANCER (2017)
Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications
Mariona Cabo et al.
ONCOIMMUNOLOGY (2017)
Oncogenic Driver Genes and the Inflammatory Microenvironment Dictate Liver Tumor Phenotype
Matthias S. Matter et al.
HEPATOLOGY (2016)
Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment
Yan Cui et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype
Daniela Bossi et al.
CANCER DISCOVERY (2016)
Clinical significance of tumor-infiltrating lymphocytes in breast cancer
Sasha E. Stanton et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Molecular biomarkers screened by next-generation RNA sequencing for non-sentinel lymph node status prediction in breast cancer patients with metastatic sentinel lymph nodes
Feng Liang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity
Wedad M. Hanna et al.
MODERN PATHOLOGY (2014)
分享论文
